rolofylline has been researched along with Electrolytes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karasawa, A; Kobayashi, T; Kusaka, H; Yamagata, T | 1 |
| Karasawa, A; Kusaka, H; Nagashima, K; Sato, K | 1 |
| Karasawa, A; Nagashima, K | 1 |
3 other study(ies) available for rolofylline and Electrolytes
| Article | Year |
|---|---|
Diuretic effects of KW-3902, a novel adenosine A1-receptor antagonist, in anesthetized dogs.
Topics: Anesthesia; Animals; Diuretics; Dogs; Electrolytes; Female; Furosemide; Glomerular Filtration Rate; Hemodynamics; Male; Purinergic P1 Receptor Antagonists; Renal Circulation; Trichlormethiazide; Urodynamics; Xanthines | 1994 |
Effects of KW-3902, a novel adenosine A1-receptor antagonist, on cephaloridine-induced acute renal failure in rats.
Topics: Acute Kidney Injury; Animals; Cephaloridine; Diuretics; Electrolytes; Furosemide; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Trichlormethiazide; Xanthines | 1994 |
Effects of KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine), an adenosine A1-receptor antagonist, on urinary excretions of various electrolytes in rats.
Topics: Animals; Diuretics; Electrolytes; Kidney Tubules; Male; Osmolar Concentration; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Xanthines | 1996 |